The Intelligence Layer For Public Markets

Discover The Signals Before They Become Consensus.

Monitor insider buying, activist campaigns, institutional accumulation and corporate catalysts through a single intelligence platform.

Scroll
Continuous Coverage
SEC Form 4·Schedule 13D·13F-HR·Form 8-K·LSE RNS·FI Insynsregistret·Share Buybacks·Government Contracts·Activist Campaigns·Institutional Flows·

The Problem

Markets Generate Millions Of Signals. Most Are Noise.

Every day, thousands of filings, disclosures, announcements and transactions enter the market. Most investors never see them. Most platforms overwhelm users with data.

Information is abundant.
Intelligence is scarce.

4,812Filings Analysed · Today
37Insider Clusters
0High Conviction Signals
6 MinSince Last Refresh

Framework

How Sentra Thinks

Four lenses applied to every signal. Conviction emerges where they converge.

Smart Money

01
  • Insider Buying
  • Activists
  • Institutions

Catalysts

02
  • Spin-offs
  • Buybacks
  • Contracts

Mispricing

03
  • Valuation
  • Dislocations
  • Turnarounds

Future Relevance

04
  • AI
  • Defence
  • Infrastructure
  • Biotechnology

Example Signal

What An Intelligence Signal Looks Like

Not a price target. A scored, reasoned briefing — the way an analyst would frame it for an investment committee.

KBR Insider Cluster

KBR, Inc. · NYSE: KBR

Brief · SEN-0427  ·  Compiled from public filings · 11 Jun 2026

Conviction 0 / 100
Cluster Value$4.93M
Insiders3
Window10days
Off 52-Wk High15.3%
Market Cap$8.5B
Insider Transactions
DateInsiderRole SharesPriceValue
02 JunCarlos M. HernandezDirector16,000$61.84$0.99M
08 JunMark W. SoppEVP, CFO38,500$62.71$2.41M
11 JunLester L. LylesDirector, Chair24,000$63.42$1.52M
Aggregate · open-market (code P) 78,500 $62.71 $4.93M
Market & Valuation
Last$62.94
EV / EBITDA11.5×
Peer Median13.2×
FCF Yield5.4%
Backlog$21.5B
Conviction Scoring
  • Cluster density & size88
  • Signal timing vs catalyst85
  • Buyer seniority87
  • Corroboration overlay80
  • Valuation support62

Weighted composite 87 / 100 · liquidity-adjusted — large-cap NYSE listing, ample volume, no execution haircut applied.

Why It Matters

Three directors purchased in size within ten trading days, immediately following a margin-accretive government services award. Cluster buying of this density and timing has historically preceded re-rating in the name — the insiders are signalling conviction the market has not yet priced.

Catalysts
  1. Q3 FY26 · AugFiscal-Q1 results and guidance; segment margin watched for the high-technology mix-shift.
  2. Sep FY26Sustainable Technology Solutions licensing decisions, est. $0.8–1.2B aggregate ceiling.
  3. Q4 FY26 · NovGovernment Solutions recompetes; ~$3B of ceiling value up for award or extension.
  4. H1 FY27Capital-return framework review against ~$450M trailing FCF and ~1.6× net leverage.
Risks
  1. Q3–Q4 FY26Continuing-resolution timing can defer task-order funding on programs at a low-double-digit % of revenue.
  2. FY26–27Integration execution on recent acquisitions; synergies unrealised, interim margin dilution possible.
  3. OngoingProgram concentration — a handful of contracts drive an outsized share of segment profit.
  4. FY26Labour and subcontractor cost inflation on cost-reimbursable work; fee capped, recovery lags.
What We're Watching
  1. Next 30 daysForm 4 follow-through — whether the cluster extends or officers file further code-P buys.
  2. Into Q3 FY26Award cadence against the $21.5B backlog; book-to-bill above 1.0× confirms conversion.
  3. Aug 14Q2 13F deadline — net additions among top holders as accumulation confirmation.
  4. Q3–Q4 FY26Segment EBITDA margin progression toward the low-teens.
Sources · SEC Form 4 · public award filings · point-in-time pricing Illustrative example — not a recommendation
Sentra signal briefing — KBR insider cluster, conviction 87/100: a $4.93M cluster across three directors, the full transaction ledger, market and valuation snapshot, conviction scoring and catalyst calendar.

Philosophy

We Don't Track Stocks. We Track Change.

When insiders buy.

When activists emerge.

When institutions accumulate.

When corporate catalysts begin to matter.

When the odds shift.

Sentra is designed to identify those moments — the few that genuinely change the odds.

Intelligence Report

The Full Briefing

What members receive — a complete, balanced memo. The bull case and the bear case, stated with equal rigour.

Intelligence Memo Activist · Institutional

Avantor, Inc. · NYSE: AVTR

Memo · SEN-0613  ·  Compiled from public filings · 12 Jun 2026

Conviction0
Horizon12–18M
Market Cap$14.0B
EV / EBITDA13.0×
Net Leverage3.5×
Activist Stake6.4%
Signal Summary

An activist has disclosed a position and is pressing for portfolio rationalisation. Concurrent institutional accumulation over two quarters suggests the campaign is gaining alignment. The setup pairs a credible catalyst path with a depressed valuation relative to life-science tools peers.

Activist Position
The originating signal
Filer
Meridian Harbour Partners LP illustrative
Vehicle
Schedule 13D/A — Amendment No. 1
Disclosed
13D 04 Mar 2026 · amended 02 Jun 2026
Stake
6.4% · ~43.2M shares · ~$910M
Objective
Divest lower-margin Laboratory Solutions; accelerate deleveraging
Engagement
Two board seats sought · two nominees · open letter 02 Jun 2026
Institutional Flow
Corroboration · trailing two 13F cycles
Net Shares · 2Q+24.6M
Est. Value$516M
Inst. Ownership94.0%
Adding / Trimming412 / 287
HolderSharesQ / QPosition
Index & ETF complex96.4M+2.1MAdded
Global value manager38.7M+6.9MAdded
Multi-strategy platform19.2M+19.2MNew
Diversified pension11.5M−0.8MTrimmed

Net institutional buying across both cycles, breadth skewed to accumulation (412 increasing against 287 decreasing). Next 13F window — 14 Aug 2026.

Valuation & Balance Sheet
EV / EBITDA (fwd)13.0×Peer median 17.5×
Forward P / E16.5×
FCF Yield6.0%Trailing twelve months
Net Debt / EBITDA3.5×~$4.2B net debt
Interest Coverage3.9×Rate-sensitive
Discount To Peers~26%On forward EV / EBITDA
Lab Solutions
~$4.5B revenue · ~12% margin · activist-targeted
Bioscience Prod.
~$2.3B revenue · ~28% margin · retained core
Bull Case
What goes right
  • Activist forces divestiture of the lower-margin segment, lifting group margins.
  • Deleveraging accelerates as proceeds reduce a heavy interest burden.
  • Re-rating toward life-science tools peers as the narrative simplifies.
Bear Case
What goes wrong
  • Management resists; the campaign stalls into a protracted proxy fight.
  • End-market softness pressures the core before any catalyst lands.
  • Leverage limits flexibility if rates stay higher for longer.
Catalyst Timeline
On the calendar
  1. Q4 FY26 · Oct–DecStrategic-review outcome; likely disclosed with the Q3 print in early November.
  2. 14 Aug 2026Q2 13F deadline — next institutional-ownership read on the accumulation trend.
  3. H2 FY26Capital markets day — first updated margin framework since the activist disclosure.
  4. Late Jul 2026Q2 earnings — first management commentary into the review window.
What We're Watching
Triggers to escalate conviction
  • A board seat or standstill settlement with the activist.
  • A formally announced divestiture process for the lower-margin segment.
  • Form 4 open-market insider purchases (code P) confirming internal alignment.
  • A second activist or a 13D amendment raising the stake.
Conviction Composition
Four-lens breakdown · composite 79 / 100
  • Smart Money84
  • Mispricing81
  • Catalyst path76
  • Future relevance71

Held short of the 80s by a missing insider-buying corroborator and ~3.5× leverage that limits margin for error before the review lands.

Sources SEC Schedule 13D · Form 13F-HR · Form 10-Q · company disclosures. Point-in-time as of public dissemination.

Illustrative example compiled from public filings. For information only — not investment advice, not a recommendation, and not a price target. Capital at risk.

Sentra intelligence memo — Avantor (NYSE: AVTR), conviction 79, horizon 12–18 months: activist position, institutional flow, valuation and balance sheet, bull and bear cases, catalyst timeline and a four-lens conviction breakdown.

Membership

One Membership. Everything Sentra Sees.

Everything Sentra sees.

Everything Sentra scores.

Everything Sentra publishes.

No tiers. No enterprise upsell. No free plan diluting the work. One price, for the full intelligence stream.

Membership

Everything Sentra sees. Everything Sentra scores. Everything Sentra publishes.

£9.99/month
  • Daily Intelligence Briefings
  • Insider Cluster Alerts
  • Activist Tracking
  • AI Intelligence Reports
  • Telegram Access
  • Future Platform Updates

Cancel anytime. No contracts. Founding members keep their pricing as Sentra grows.

The Next Opportunity Won't Announce Itself.

Sentra helps you find it first.